Exchange: NASDAQ·Updated 10:51 AM EDT
TVRD logo

TVRD Tvardi Therapeutics, Inc.

$1.71
$0.095
(5.90%)
Today
EarningsNov 12
Mkt Cap$21.48M
Vol53,852.00

About TVRD

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
30

Bearish Sentiment

How do you feel about TVRD?

Advertisement|Remove ads.